XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2017   10,829,918    
Beginning balance at Dec. 31, 2017 $ 181,321 $ 61,855 $ 121,144 $ (1,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 11,240   11,240  
Net unrealized loss on securities available for sale, net of tax (4,344)     (4,344)
Net unrealized loss on cash flow hedging derivative instruments, net of tax 522     522
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax (15)     (15)
Comprehensive income 7,403   11,240 (3,837)
Cash dividends declared (5,754)   (5,754)  
Equity compensation expense 190 $ 190    
Payment to repurchase common stock (in shares)   (5,725)    
Payment to repurchase common stock (166)   (166)  
Issuance of restricted stock (in shares)   16,795    
Proceeds from sale of common stock (in shares)   10,929    
Proceeds from sale of common stock $ 310 $ 310    
Ending balance (in shares) at Jun. 30, 2018 10,851,917 10,851,917    
Ending balance at Jun. 30, 2018 $ 183,304 $ 62,355 126,464 (5,515)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,734      
Net unrealized loss on securities available for sale, net of tax (1,035)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ (7)      
Ending balance (in shares) at Jun. 30, 2018 10,851,917 10,851,917    
Ending balance at Jun. 30, 2018 $ 183,304 $ 62,355 126,464 (5,515)
Beginning balance (in shares) at Dec. 31, 2018 10,862,651 10,862,651    
Beginning balance at Dec. 31, 2018 $ 191,542 $ 62,855 132,460 (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 12,551   12,551  
Net unrealized loss on securities available for sale, net of tax 7,801     7,801
Net unrealized loss on cash flow hedging derivative instruments, net of tax (1,363)     (1,363)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 7     7
Comprehensive income 18,996   12,551 6,445
Cash dividends declared (6,424)   (6,424)  
Equity compensation expense 244 $ 244    
Payment to repurchase common stock (in shares)   (4,104)    
Payment to repurchase common stock (94)   (94)  
Issuance of restricted stock (in shares)   19,087    
Proceeds from sale of common stock (in shares)   12,602    
Proceeds from sale of common stock $ 329 $ 329    
Ending balance (in shares) at Jun. 30, 2019 10,890,236 10,890,236    
Ending balance at Jun. 30, 2019 $ 204,593 $ 63,428 138,493 2,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,395      
Net unrealized loss on securities available for sale, net of tax 4,289      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 4      
Ending balance (in shares) at Jun. 30, 2019 10,890,236 10,890,236    
Ending balance at Jun. 30, 2019 $ 204,593 $ 63,428 $ 138,493 $ 2,672